[1]
Wang, X. 2022. Stocks Valuation of Johnson & Johnson (J&J): Analysis of Ongoing Risks of Pharmaceuticals Corporations in Post-Pandemic Era. Highlights in Business, Economics and Management. 1, (Nov. 2022), 36–40. DOI:https://doi.org/10.54097/hbem.v1i.2315.